SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 76923.00
87.22 (0.11%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Windlas Biotech Ltd.	Q V PT	1,769 Small Cap	858.60 (0.18%)	26.62	3.44	16.15	15.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Neuland Laboratories Ltd.	Q V+ PT	24,345 Small Cap	18,887 (-0.47%)	67.05	13.05	16.64	37.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Gufic Biosciences Ltd.	Q V PT	3,826 Small Cap	381.95 (0.10%)	60.59	5.76	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Global Health Ltd.	Q V PT	37,844 Small Cap	1,406.65 (-0.06%)	76.27	9.41	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Supriya Lifescience Ltd.	Q V+ PT	6,799 Small Cap	833.30 (-1.36%)	32.51	5.68	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Caplin Point Laboratories Ltd.	Q V PT	19,939 Small Cap	2,613.55 (-0.37%)	31.09	5.56	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Syncom Formulations (India) Ltd.	Q V PT	1,240 Small Cap	13.08 (-0.83%)	16.31	3.01	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,436 Small Cap	5,027.45 (-0.27%)	34.75	7.04	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Sai Life Sciences Ltd.	Q V+ PT	27,347 Small Cap	1,291.45 (0.26%)	80.08	10.9	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Natco Pharma Ltd.	Q V PT	16,606 Small Cap	925.15 (-0.22%)	11.71	1.8	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,127 Small Cap	130.45 (0.00%)	N/A	N/A	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	CORONA Remedies Ltd.	Q V+ PT	12,807 Small Cap	2,092.45 (-0.08%)	69.28	17.17	19.49	18.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Poly Medicure Ltd.	Q V PT	17,025 Small Cap	1,670.15 (-0.57%)	50.67	5.58	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	Viyash Scientific Ltd.	Q V PT	11,352 Small Cap	255.65 (-1.62%)	64.03	4.2	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Rainbow Childrens Medicare Ltd.	Q V PT	15,076 Small Cap	1,474.10 (-0.69%)	60.3	8.95	20.26	35.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Jupiter Life Line Hospitals Ltd.	Q V PT	10,728 Small Cap	322.10 (-1.57%)	56.06	6.67	21.03	54.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Artemis Medicare Services Ltd.	Q V PT	4,408 Small Cap	278.40 (-0.02%)	42.61	5.07	21.41	79.02	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,815 Small Cap	2,650.95 (-2.29%)	41.8	8.47	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Eris Lifesciences Ltd.	Q V PT	19,400 Small Cap	1,393.10 (-0.49%)	31.32	4.97	21.92	3.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Marksans Pharma Ltd.	Q V+ PT	11,941 Small Cap	258.90 (-1.75%)	39.71	7.23	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Astrazeneca Pharma India Ltd.	Q V PT	20,420 Small Cap	8,105 (-0.77%)	108.89	23.57	22.84	15.69	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Fortis Healthcare Ltd.	Q V+ PT	71,140 Mid Cap	941.95 (-0.04%)	308.84	7.71	23.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Sigachi Industries Ltd.	Q V+ PT	991 Small Cap	25.43 (-1.93%)	N/A	2.08	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Narayana Hrudayalaya Ltd.	Q V PT	41,974 Mid Cap	2,070.10 (0.79%)	52.1	9.25	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Innova Captab Ltd.	Q V PT	5,527 Small Cap	966.05 (0.02%)	66.04	6.23	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Dr. Agarwals Health Care Ltd.	Q V PT	15,076 Small Cap	487.60 (2.53%)	113.19	7.44	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Max Healthcare Institute Ltd.	Q V PT	1,08,476 Mid Cap	1,112.35 (-0.20%)	75.2	10.23	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,132 Small Cap	841.90 (-0.25%)	85.24	5.02	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Indegene Ltd.	Q V+ PT	12,241 Small Cap	510.70 (0.50%)	30.52	3.96	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Rubicon Research Ltd.	Q V+ PT	25,860 Small Cap	1,563.90 (0.11%)	137.43	19.11	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Onesource Specialty	1,744.75	3.26%
Dr. Agarwals Health	487.60	2.53%
Metropolis Health.	590.30	2.17%
Laurus Labs	1,745.85	1.84%
Cipla	1,434.80	1.77%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Acutaas Chemicals	3,121.05	-7.35%
Senores Pharmaceutic	1,317.55	-6.66%
Suven Life Sciences	297.85	-4.44%
Wanbury	318.55	-3.82%
Panacea Biotec	418.10	-3.51%

News about Top Pharma Companies in India

Jul, 2026

Eris Lifesciences informs about board meeting

Eris Lifesciences has informed that a Meeting of the Board of Directors of the Company is scheduled on Wednesday, July 29, 2026, to, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2026. Further, as informed by them vide letter dated June 26, 2026, the trading window has been already closed from July 01, 2026, and will remain closed till 48 hours after the declaration of financial results of the Company pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015, and Policy on ‘Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company’.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Rainbow Children’s Medicare informs about ESG rating

Pursuant to Regulation 30 of the SEBI Listing Regulations read with Schedule III thereto and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, Rainbow Children’s Medicare has informed that CRISIL ESG Rating & Analytics (‘CRISIL ESG’) has on a voluntary basis assessed the overall Environmental, Social and Governance (ESG) and has assigned an ESG rating of 61 and a Core ESG rating of 73, based on disclosures for FY 2025-26, on July 22, 2026. The ESG rating of 61 reflects an improvement from ‘Adequate’ to ‘Strong’ ESG rating assigned to the Company for FY 2024-25 and FY 2023-24. The Company has not engaged CRISIL ESG for ESG Ratings. CRISIL ESG has independently prepared the report based on data pertaining to FY 2025-26 for the Company available in public domain.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Rubicon Research soars on acquiring manufacturing facility in New Jersey, US

This site will focus on the company’s specialty and high value products as well as demand from US government departments

Jul, 2026

Supriya Lifescience informs about newspaper advertisement

In terms of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed copies of the newspaper advertisement extract for Postal Ballot Notice published in the newspapers, Financial Express (English Language) and Loksatta (Marathi Language).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Rubicon Research acquires manufacturing facility in New Jersey, US

This site will focus on the company’s specialty and high value products as well as demand from US government departments

Jul, 2026

Sigachi Industries submits board meeting intimation

Sigachi Industries has informed that pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled to be held on Monday, July 27, 2026 through Video Conference to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026; and any other business with the permission of the Chair.

The above information is a part of company's filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Jubilant Pharmova Ltd.	15,582 Crore
2	Suven Life Sciences Ltd.	8,807 Crore
3	Aster DM Quality Care Ltd.	70,000 Crore
4	Panacea Biotec Ltd.	2,654 Crore
5	Sanofi India Ltd.	7,760 Crore
6	Nectar Lifesciences Ltd.	202 Crore
7	Novartis India Ltd.	4,023 Crore
8	Aurobindo Pharma Ltd.	89,115 Crore
9	Apollo Hospitals Enterprise Ltd.	1,27,149 Crore
10	Solara Active Pharma Sciences Ltd.	2,439 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,893	59,102	38.08	12.45	26.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,922	1,90,832	88.21	22.69	45.79	29.04
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,358	42,278	40.04	9.35	27.05	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,631	67,124	30.72	4.80	22.28	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,746	92,623	105
Sai Life Sciences Ltd. (S)	Very Good	1,291	27,347	53.73
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,922	1,90,832	39.27
Aurobindo Pharma Ltd. (M)	Very Good	1,553	89,115	38.01
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	23.52
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,291	27,347	80.08	10.90	42.11	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,358	42,278	40.04	9.35	27.05	13.54
Mankind Pharma Ltd. (M)	Very Good	2,587	1,05,357	51.71	6.44	32.38	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,109	1,10,523	21.93	4.25	13.45	13.52
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,405	1,10,189	20.66	4.92	11.95	32.37
Abbott India Ltd. (M)	Very Good	27,893	59,102	38.08	12.45	26.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,146	96,063	29.81	2.52	15.31	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,109	1,10,523	21.93	4.25	13.45	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,984	4,73,509	41.25	5.67	23.65	14.41

You have 7 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Eris Lifesciences informs about board meeting

Rainbow Children’s Medicare informs about ESG rating

Rubicon Research soars on acquiring manufacturing facility in New Jersey, US

Supriya Lifescience informs about newspaper advertisement

Rubicon Research acquires manufacturing facility in New Jersey, US

Sigachi Industries submits board meeting intimation

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.